P50.12 A Novel Nomogram and Risk Classification System Predicting the Survival of Patients with Extensive-stage Small Cell Lung Cancer
T. Mei,X. Yang,W. Xiu,Y. Yu,J. Zhu,Y. Zhang,M. Huang,F. Peng,M. Yu,Y. Li,L. Zhou,J. Xue,X. Zhou,Y. Liu,B. Zou,Y. Xu,Y. Wang,Y. Lu,Y. Gong
DOI: https://doi.org/10.1016/j.jtho.2021.01.1651
IF: 20.121
2021-01-01
Journal of Thoracic Oncology
Abstract:5-year OS was analyzed using Kaplan-Meier curves and survival between groups was compared with the log-rank test.Univariate and multivariable Proportional Hazards models were used to determine predictors of OS.Results: We identified 148 patients.76 were TCs, 31 ACs, and 41 had unspecified histology.Median age was 65 years (range 22-83) and the majority were female (71%).20% were African American; 46% were nonsmokers.Pathologic stages were 0 (3%), I (74%), II (16%), and III (8%).Surgical procedures were 8% wedge resection, 76% lobectomy, 5% bilobectomy, 4% pneumonectomy, 5% segementectomy, and 2% lobecto-my+wedge.Median follow-up time was 42 months.Patients with ACs were significantly older (p¼0.0004) and more likely to be later pathologic stage (p¼0.0175)than TCs/unspecifieds but did not differ in sex, race, smoking status, surgical technique, extent of resection, number of lymph nodes sampled, or 30-day postoperative mortality.The combined 5-year OS rate was 84% (95% CI: 74%-91%); 49% for atypical, 91% typical (p¼ 0.0003).Patients with pathologic N1/N2 nodal metastases had a significantly decreased OS compared to those without nodal disease (p¼0.0048).Multivariable models showed that atypical histology (p¼0.0055),male sex (p¼0.0093), and pathologic N1/N2 nodal metastases (p¼0.0281)remained significant negative predictors of OS after adjusting for age at surgery.Conclusion: Our results are consistent with previous reports showing that TCs and ACs have different disease characteristics, with ACs having a worse prognosis following resection.However, it is unknown to what extent other prognostic factors are involved.We found that presence of nodal metastasis (N1/N2) and sex were additional predictors of OS for patients with carcinoid tumors.Future studies should assess the involvement of pathologic stage and lymph node involvement which could lead to an improvement in prognostication and patient management.